Literature DB >> 22362760

Antithrombin-independent effects of heparins on fibrin clot nanostructure.

Christelle Yeromonahos1, Raphaël Marlu, Benoît Polack, Francois Caton.   

Abstract

OBJECTIVE: Because of the widespread clinical use of heparins, their effects on the enzymatic cascade are very well known. In contrast, little is known about the direct effect of heparins on the nanostructure of fibrin fibers, even though this nanostructure plays a major role in the mechanical strength and lysis of clots. This lack of reliable data can be correlated with the lack of a nonintrusive, quantitative method to determine this structure. We recently developed such a method that allows the simultaneous determination of the average fiber radius and the protein content using spectrometric data. In this study, we assessed the nanostructure of fibrin in a system composed of human thrombin and fibrinogen. METHODS AND
RESULTS: We provide quantitative evidence showing that both unfractionated heparin and low molecular weight heparin directly alter the nanostructure of fibrin fibers independent of their other actions on the coagulation cascade; as expected, the pentasaccharide fondaparinux has no effect.
CONCLUSIONS: Our results show that in addition to the effect of heparin on the coagulation cascade, modifications of the fibrin nanostructure may also contribute to improved fibrinolysis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22362760     DOI: 10.1161/ATVBAHA.112.245308

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  12 in total

1.  Tumor microenvironment and clonal monocytes from chronic myelomonocytic leukemia induce a procoagulant climate.

Authors:  Johanna Zannoni; Natacha Mauz; Landry Seyve; Mathieu Meunier; Karin Pernet-Gallay; Julie Brault; Claire Jouzier; David Laurin; Mylène Pezet; Martine Pernollet; Jean-Yves Cahn; Fabrice Cognasse; Benoît Polack; Sophie Park
Journal:  Blood Adv       Date:  2019-06-25

Review 2.  Mechanisms of fibrin polymerization and clinical implications.

Authors:  John W Weisel; Rustem I Litvinov
Journal:  Blood       Date:  2013-01-10       Impact factor: 22.113

3.  Aggregates Dramatically Alter Fibrin Ultrastructure.

Authors:  Xabel García; Landry Seyve; Zera Tellier; Guillaume Chevreux; Nicolas Bihoreau; Benoît Polack; Francois Caton
Journal:  Biophys J       Date:  2019-11-02       Impact factor: 4.033

Review 4.  Fibrinogen and Fibrin in Hemostasis and Thrombosis.

Authors:  Sravya Kattula; James R Byrnes; Alisa S Wolberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-03       Impact factor: 8.311

Review 5.  Prothrombotic Fibrin Clot Phenotype in Patients with Deep Vein Thrombosis and Pulmonary Embolism: A New Risk Factor for Recurrence.

Authors:  Anetta Undas
Journal:  Biomed Res Int       Date:  2017-06-27       Impact factor: 3.411

6.  Fibrinography: A Multiwavelength Light-Scattering Assay of Fibrin Structure.

Authors:  Carhel Dassi; Landry Seyve; Xabel García; Emmanuelle Bigo; Raphaël Marlu; François Caton; Benoît Polack
Journal:  Hemasphere       Date:  2019-01-24

7.  Development of a mesoscopic framework spanning nanoscale protofibril dynamics to macro-scale fibrin clot formation.

Authors:  Naoki Takeishi; Taiki Shigematsu; Ryogo Enosaki; Shunichi Ishida; Satoshi Ii; Shigeo Wada
Journal:  J R Soc Interface       Date:  2021-11-10       Impact factor: 4.118

8.  Delayed intra-abdominal bleeding following trans-vaginal ultrasonography guided oocyte retrieval for in vitro fertilization in patients at risk for thrombo-embolic events under anticoagulant therapy.

Authors:  Roy Mashiach; David Stockheim; Mati Zolti; Raoul Orvieto
Journal:  F1000Res       Date:  2013-09-16

9.  Free Fatty Acids Modulate Thrombin Mediated Fibrin Generation Resulting in Less Stable Clots.

Authors:  Anna Tanka-Salamon; Erzsébet Komorowicz; László Szabó; Kiril Tenekedjiev; Krasimir Kolev
Journal:  PLoS One       Date:  2016-12-12       Impact factor: 3.240

10.  Comparison of antithrombin-dependent and direct inhibitors of factor Xa or thrombin on the kinetics and qualitative characteristics of blood clots.

Authors:  Stella Salta; Loula Papageorgiou; Annette K Larsen; Patrick Van Dreden; Claire Soulier; Dennis V Cokkinos; Ismail Elalamy; Grigoris T Gerotziafas
Journal:  Res Pract Thromb Haemost       Date:  2018-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.